An IBB project led by Salvador Ventura has been one of six selected by the Multiple System Atrophy Coalition in its research grant programme. The grant will allow researchers to advance in the study of molecules they have identified as being potential candidates for a treatment of multiple system atrophy. This neurodegenerative disease affects more than 30,000 people in Europe.
A study by the ICTA-UAB analyses different proposals for the implementation of telework based on mobility and air quality data obtained in Barcelona during the lockdown.
The UAB will be taking part in a new ECIU University project called BOOGIE U. The project, funded by the European Institute of Innovation and Technology (EIT), aims to boost EU sustainable economic growth and competitiveness by executing novel models for increasing Innovation and Entrepreneurial (I&E) capacity within the consortium. In doing so, the project aims to contribute to the evolution of local innovation systems.
An international collaboration has identified several genetic markers associated with the SARS-CoV-2 infection and the severity of the disease. The research, published in Nature, included the involvement of the IBB.
Researchers at the UAB describe the mechanism through which a non-toxic derivative of the tetanus neurotoxin (Hc-TeTx) may serve to treat depression and neurodegenerative diseases, as has already been demonstrated in animal models.
Through its Microscopy Service, the UAB forms part of the NFFA-Europe project, which provides researchers across Europe with a wide array of scientific and technical services. Applications for access can be sent in until 1 September.
UAB, UPC and Vall d'Hebron researchers have developed a mobile application that could be useful in the assessment of the severity of fatigue in this syndrome, especially in women. The technology uses a chest strap that measures heart rate variability.